image

The best stocks to buy since 1993

Latest issue now available

Sinclair Pharma - Decapinol mouthwash news due any day

February 2005

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • SPH
  • Price:
  • 136p
Over the month we met again with Dr Michael Flynn, chief executive of Sinclair Pharma (SPH;136p). The first time was back in December ‘03 shortly after the company floated although we didn’t write about it at the time. The placing back then at 115p had raised £8.9m new money for the company to value it at £61.8m. Having been as high as 153p and as low as 93p, the shares have resumed their uptrend. The pharma / biotech industry is well known for its long time frames, high level of risks and high expenditure. Where Sinclair is different is that it has a search and development philosophy to avoid these three disappointments. Its particular expertise is in buying products that are close to the market but that h ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

LIMITED PERIOD OFFER

SUBSCRIBE TODAY AND SAVE £40 WITH OFFER CODE 40OFFSCSW

To access our archive of articles and to receive current issues you need to subscribe